Immuneering to Present at the 35th Annual Piper Sandler Healthcare Conference
20 nov. 2023 16h05 HE
|
Immuneering Corporation
CAMBRIDGE, Mass., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop medicines for broad populations of cancer patients...